International Oncology Network - Cancer & Hematology News
Peter Hofland, PhD's Videos (423)
ESMO 2012: 2084 - A Play in 3 Acts
2084 parodies a dystopia of the future but visualised in terms of the hurdles placed in the way of… Peter Hofland, PhD Oct 19, 2012 31 views
ESMO 2012: The Era of Personalized Medicine is Close but Not Here Yet!
Martine Piccart, ESMO President, calls for more international collaboration to make personalized me… Peter Hofland, PhD Oct 19, 2012 16 views
ESMO 2012: Duration of Trastuzumab in HER2-positive Early Breast Cancer: What is the Standard?
Sandra Swain compares results of the PHARE and the HERA trials about the optimal duration of trastu… Peter Hofland, PhD Oct 19, 2012 15 views
ESMO 2012: Pazopanib, Another Drug in the Arsenal of Weapons Against Renal Cell Cancer
Cora Sternberg describes an interesting phase III study confirming the positive results for a new d… Peter Hofland, PhD Oct 19, 2012 17 views
ESMO 2012: Awaited Results of a Long-term Academic Study in Sarcoma
Jean-Yves Blay explains the results of a large trial in sarcoma and helps us understand what we sho… Peter Hofland, PhD Oct 19, 2012 16 views
ESMO 2012: The Cost of Personalized Medicine Should Not be a Problem of Medical Oncologists...!
Christoph Zielinski discusses the latest advances in cancer research and points out the need for a… Peter Hofland, PhD Oct 19, 2012 6 views
ESMO 2012: Whole Genome Approach - Feasible in Daily Practice?
Sherene Loi and Peter Dubsky dissect the results of the national SAFIR-02 study using whole-genome… Peter Hofland, PhD Oct 19, 2012 10 views
ESMO 2012: Bevacizumab for First and Second-line Beyond Progression in Colorectal Cancer
Jean-Yves Douillard explores the BEBYP academic trial and highlights differences to previous studie… Peter Hofland, PhD Oct 19, 2012 14 views
ESMO 2012 : Adjuvant Treatments for Colorectal Cancer
Fortunato Ciardiello offers explanation on the failure of targeted therapy in adjuvant treatment of… Peter Hofland, PhD Oct 19, 2012 6 views
ESMO 2012: Hepatocellular Carcinoma - Need to Search for More Effective Treatments
Roberto Labianca offers an overview of studies presented and calls for different strategies in the… Peter Hofland, PhD Oct 19, 2012 16 views
ESMO 2012: Being Small in Size is Not Always Better in CNS Disease
Evandro de Azambuja and Matthias Preusser describe results of the CEREBEL trial looking into future… Peter Hofland, PhD Oct 19, 2012 6 views
ESMO 2012 : Misunderstandings about Cancer Risk Factors
Derek Power reports myths and misunderstandings hampering efforts to prevent cancer. This study was… Peter Hofland, PhD Oct 19, 2012 8 views
ESMO 2012 : Crizotinib, a Ready to Use Drug for NSCLC
Luis Paz-Ares describes results of a new drug for ALK-positive NSCLC patients. These studies were p… Peter Hofland, PhD Oct 19, 2012 6 views
ESMO 2012 : Lung Cancer and Women
Enriqueta Felip and Silvia Novello send important messages about new findings revealing unprecedent… Peter Hofland, PhD Oct 19, 2012 2 views
ESMO 2012 : Where are the Most Promising Developments for the Future of Cancer Treatment?
Elisabeth Eisenhauer digs into promises and myths of future drugs against cancer. These studies wer… Peter Hofland, PhD Oct 19, 2012 2 views
ESMO 2012 : EGFR vs. ALK Populations in Lung Cancer
Jean-Charles Soria discusses future treatments for selected lung cancer patients. These studies wer… Peter Hofland, PhD Oct 19, 2012 10 views
ESMO 2012: Improving Outlook for Ovarian Cancer
Andres Cervantes Ruiperez explains which weapons are available against ovarian cancer, still a very… Peter Hofland, PhD Oct 19, 2012 4 views
ESMO 2012: Combination of Inhibitors Effective for Melanoma
Ulrich Keilholz describes important studies using combined drugs to expose the Achilles' heels of m… Peter Hofland, PhD Oct 19, 2012 1 view
ESMO 2012: What Personalized Medicine Practically Means for Cancer Patients
Cancer treatment is being transformed as scientists discovered the molecular changes at the heart o… Peter Hofland, PhD Oct 19, 2012 4 views
ESMO 2012: The Economic and Human Cost of Cancer in Europe
Cancer costs a lot of money. New studies that reveal for the first time the real economic and human… Peter Hofland, PhD Oct 19, 2012 4 views
ADVERTISEMENT
Bookmark / Share
Join the Conversation!
© 2013 Created by Peter Hofland, PhD.
